Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Clinical trial NCT02481154 · COMPLETED
Trial details
- NCT number
- NCT02481154
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2022-10-17
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.